Q.1
Revenue growth of Krebs Biochemicals & Industries Ltd?
Krebs Biochemicals & Industries Ltd revenue growth is -14.1% for FY-2025 , which is below its 5 year CAGR of 5.3% , indicating slower growth.
Q.2
Gross Profit margin of Krebs Biochemicals & Industries Ltd?
Krebs Biochemicals & Industries Ltd Gross profit margin which is the profit after deduction of direct costs, is -46.7% for FY-2025 , which is below its 5 year median of -43.3% , indicating decreasing margins.
Q.3
Operating Profit Margin of Krebs Biochemicals & Industries Ltd?
Krebs Biochemicals & Industries Ltd Operating Profit Margin which is the profit after deduction of all operating costs, is -34.7% for FY-2025 , which is below its 5 year median of -32.73% indicating decreasing margins.
Q.4
Net Profit Margin of Krebs Biochemicals & Industries Ltd?
Krebs Biochemicals & Industries Ltd Net Profit Margin is -62.2% for FY-2025 , is below with its 5 year median of -52.81%, indicating decreasing margins.
|
Current Level |
Historic Median |
|
Gross Profit Margin |
-46.7 |
-43.3 |
|
Operating Profit Margin |
-34.7 |
-32.73 |
|
Net Profit Margin |
-62.2 |
-52.81 |
Q.5
Return on Asset of Krebs Biochemicals & Industries Ltd?
Krebs Biochemicals & Industries Ltd Return on Asset is -15.52%, which is in line with its 5 year historical median of -15.52%, indicating stable asset utilization efficiency.
Q.6
Return on Equity (ROE) of Krebs Biochemicals & Industries Ltd?
Krebs Biochemicals & Industries Ltd Return on equity is 0% for FY-2025 , which is in line with its historical median of 0%, indicating the business is making similar use of its shareholders capital.
Q.7
Return on capital employed (ROCE) of Krebs Biochemicals & Industries Ltd?
Krebs Biochemicals & Industries Ltd Return on capital employed is -29.92% for FY-2025 , which is below its estimated weighted average cost of capital(WACC) 14%, indicating value preservation.
Q.8
Cash conversion cycle of Krebs Biochemicals & Industries Ltd?
Krebs Biochemicals & Industries Ltd Cash conversion cycle is -36 days, below its historical median of 0 days, indicating improved working capital management. However, you need to compare this with its peers in the industry.
|
Current Level |
Historic Median |
|
Asset Turnover |
0.25 |
0.29 |
|
ROE |
- |
- |
|
ROCE |
-29.92 |
-29.92 |
|
Cash Conversion Cycle |
-36 days |
- |
Q.9
Debt to Equity ratio of Krebs Biochemicals & Industries Ltd?
Krebs Biochemicals & Industries Ltd Debt-to-Equity ratio is -1.45 , which is lower with the industry average of 0.15 , indicating lower debt levels in the industry.
Q.10
Debt to cash flow from operations of Krebs Biochemicals & Industries Ltd?
Krebs Biochemicals & Industries Ltd Debt to cash flow from operations is -26.89 , which is at a unhealthy level.